Johnson & Johnson (JNJ) Fundamental Analysis: Revenue, Earnings & Valuation

3.93 / 10

Netural

The security demonstrates inadequate fundamental health (3.9/10). Positive indicators: Fixed assets turnover ratio and Cost of sales ratio (%), whereas limitations surface in Total operating revenue (YoY growth rate %) and Operating revenue (YoY growth rate %). Analytical conclusion: defensive.

Analysis Checks(6/10)

Total operating revenue (YoY growth rate %)

Value6.05

Score1/3

Weight-5.63%

1M Return-0.55%

Inventory turnover ratio

Value2.27

Score3/3

Weight-5.70%

1M Return-0.51%

PB-ROE

Value1.44

Score2/3

Weight94.00%

1M Return6.89%

Fixed assets turnover ratio

Value4.31

Score2/3

Weight-7.91%

1M Return-0.77%

Interest coverage ratio (EBIT / Interest expense) (%)

Value34.97

Score2/3

Weight-11.14%

1M Return-1.10%

Diluted earnings per share (YoY growth rate %)

Value90.50

Score0/3

Weight-40.13%

1M Return-4.08%

Operating revenue (YoY growth rate %)

Value6.05

Score1/3

Weight-4.78%

1M Return-0.47%

Cost of sales ratio (%)

Value32.12

Score3/3

Weight9.59%

1M Return0.82%

Asset-MV

Value-0.55

Score1/3

Weight77.96%

1M Return5.98%

Net profit / Total profit (%)

Value82.27

Score2/3

Weight-6.25%

1M Return-0.60%

Is JNJ undervalued or overvalued?

JNJ scores 3.93/10 on fundamentals and holds a Fair valuation at present. Backed by its 35.03% ROE, 28.46% net margin, 21.97 P/E ratio, 7.22 P/B ratio, and 90.58% earnings growth, these metrics solidify its Netural investment rating.